UnitedHealth Group Incorporated (UNH)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at UnitedHealth Group Incorporated.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 2 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 414.40 $ — 89% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 14.7% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 27
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 19.81 | 18.40 – 20.11 | 446,534 | 21.2% | 25 |
| 12/31/2027 | 22.44 | 19.92 – 24.50 | 459,373 | 13.2% | 27 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 4.08 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 5.98 | 2.50 | 100,807 | 6.80 | 5.50 | 2,369 | 1,457 |
| 2025: Q1 | 6.85 | – | 109,575 | 9.80 | 5.70 | 5,456 | 4,558 |
| 2025: Q2 | 3.74 | -17.60 | 111,616 | 12.90 | 3.10 | 7,188 | 6,302 |
| 2025: Q3 | 2.57 | -60.50 | 113,161 | 12.20 | 2.10 | 5,945 | 5,055 |
| 2025: Q4 | 0.01 | -99.80 | 113,215 | 12.30 | 0.00 | 1,108 | 160 |
| 2026: Q1 | 6.90 | 0.70 | 111,721 | 2.00 | 5.60 | 8,912 | 8,149 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 184,840 | 12,930 | 7,017 | 7.25 | 9,795 | 38,397 | 122,679 |
| 2017 | 201,159 | 15,209 | 10,558 | 10.72 | 13,596 | 49,833 | 139,057 |
| 2018 | 226,247 | 17,344 | 11,986 | 12.19 | 15,713 | 51,696 | 152,221 |
| 2019 | 242,155 | 19,685 | 13,839 | 14.33 | 18,463 | 57,616 | 173,889 |
| 2020 | 257,141 | 22,405 | 15,403 | 16.03 | 22,174 | 65,491 | 197,289 |
| 2021 | 287,597 | 23,970 | 17,285 | 18.08 | 22,343 | 71,760 | 212,206 |
| 2022 | 324,162 | 28,435 | 20,120 | 21.18 | 26,206 | 77,772 | 245,705 |
| 2023 | 371,622 | 32,358 | 22,381 | 23.86 | 29,068 | 88,756 | 273,720 |
| 2024 | 400,278 | 32,287 | 14,405 | 15.51 | 24,204 | 92,658 | 298,278 |
| 2025 | 447,567 | 18,964 | 12,056 | 13.25 | 19,697 | 94,110 | 309,581 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
UnitedHealth Group Incorporated ist ein Gesundheitsunternehmen mit Geschäft in den USA und international. Es ist in vier Segmenten tätig: Optum Health, Optum Insight, Optum Rx und UnitedHealthcare.
| Employees | 390,000 |
|---|---|
| Headquarters | Eden Prairie, MN |
| Address | 1 Health Drive, 55344 Eden Prairie, United States |
| Phone | (800)-328-5979 |
| Website | unitedhealthgroup.com |
| IPO Date | 26. Oct 1984 |
| ISIN | US91324P1021 |
| Stock Split | 2:1 on 05/31/2005 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Stephen J. Hemsley | CEO & Non-Independent Non-Executive Chairman | 1953 |
| Wayne Scott DeVeydt | Chief Financial Officer | 1970 |
| Christopher R. Zaetta | Executive VP, Chief Legal Officer & Corporate Secretary | 1972 |
| Timothy John Noel | Chief Executive Officer of UnitedHealthcare Business | 1972 |
| Patrick Hugh Conway M.D., M.Sc. | Chief Executive Officer of Optum | 1975 |
| Dennis Stankiewicz | Chief Accounting Officer & Corporate Controller | 1978 |
| Sandeep Dadlani | Executive VP and Chief Digital & Technology Officer | 1975 |
| Zachary William Sopcak | Senior Vice President of Capital Markets Communications & Investor Relations | – |
| Erin L. McSweeney J.D. | Executive VP & Chief People Officer | 1965 |
| Richard J. Migliori M.D. | Executive Vice President & Senior Advisor | 1957 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.